Pharmacology of Purine and Pyrimidine Receptors
This is an overview of the fast-moving field of purinergic signalling through adenosine and ATP receptors.
Audience
Pharmacologists, immunologists, and biochemists.
Included in series
Advances in Pharmacology
Advances in Pharmacology
Hardbound, 558 Pages
Published: June 2011
Imprint: Academic Press
ISBN: 978-0-12-385526-8
Contents
- The structure of the adenosine receptors: implications for drug discovery
J. Robert Lane, Veli-Pekka Jaakola, Adriaan P. IJzerman - Adenosine Receptors in Health and Disease
Stefania Gessi, Stefania Merighi, Katia Varani, and Pier Andrea Borea - Adenosine and the Regulation of Metabolism and Body Temperature
Bertil Fredholm, Stina M. Johansson and Ying-Qing Wang - Regulation of Leukocyte Function by Adenosine Receptors
Joel Linden - Role of Adenosine A2B Receptors in Inflammation
Igor Feoktistov and Italo Biaggioni - Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
Michael Koeppen, Tobias Eckle, and Holger Eltzschig - Allosteric Modulation of Purine and Pyrimidine Receptors
Kenneth Jacobson, Zhan-Guo Gao, Aniko Göblyös, and Adriaan IJzerman - Molecular Mechanisms of Purine and Pyrimidine Nucleotide Release
Eduardo R. Lazarowski, Juliana I. Sesma, Lucia Seminario-Vidal, and Silvia M. Kreda - Impact of Ectoenzymes on Purinergic Signalling
Filip Kukulski, Sébastien A. Lévesque, and Jean Sévigny - Ectonucleotidases as Regulators of Purinergic Signaling in Inflammation and Thrombosis
Simon C. Robson and Silvia Deaglio - P2X Receptors in Health and Disease
Geoffrey Burnstock and Charles Kennedy - Molecular Pharmacology, Physiology, and Structure of the P2Y Receptors
Ivar von Kügelgen and T. Kendall Harden - P2Y Receptors in Health and Disease
David Erlinge - P2 Receptor Signaling in Neurons and Glia of the Central Nervous System
Laszlo Köles Anna Leichsenring, Patrizia Rubini and Peter Illes - Role of Purinergic Receptors in Neuroprotection
Tozaki-Saitoh Hidetoshi, Makoto Tsuda, and Kazuhide Inoue
- The structure of the adenosine receptors: implications for drug discovery

